Pediatrics billing: vaccines, well-child schedules and Medicaid variation.
Paediatric practices carry a large vaccine inventory as a working capital asset and bill a payer mix weighted toward Medicaid, where rules vary by state. Both facts shape the revenue cycle: vaccine margin depends on billing every dose and administration correctly, and Medicaid variation means a process that works in one state may fail across the border.
Key takeaways
- Vaccine inventory is capital sitting on a shelf. Every unbilled dose is a direct loss, not a deferred one.
- VFC doses must never be billed as private stock. Bill administration only, with the correct product code and modifier.
- 90460/90461 are counselling-based and pay per component. Using 90471 instead leaves money uncollected on multi-component vaccines.
- Medicaid rules are state-specific. Multi-state practices need per-state configuration, not one shared ruleset.
What paediatric billing actually involves
The paediatric revenue cycle is dominated by two things: the well-child schedule and immunisations. Well visits follow a recommended periodicity that payers largely mirror, which makes eligibility predictable but frequency limits unforgiving. A visit a few days early can deny outright. Immunisations are where the money concentrates, because the practice buys vaccine stock up front and recovers it only when both product and administration are billed correctly.
Layered on top is the Vaccines for Children programme, which supplies doses at no cost for eligible children. VFC doses may not be billed as practice stock; only the administration is billable, and the claim must identify the dose as VFC-supplied according to the state's rules. Practices that blur the two inventories create both a revenue problem and a compliance problem, and reconciling them after the fact is painful.
Coding guidelines: the codes that carry the practice
| Code | Service | What supports it | Where it goes wrong |
|---|---|---|---|
99381–99384 | New patient preventive, infant through adolescent | Age-appropriate comprehensive visit | Wrong age band; visit billed before the interval resets |
99391–99394 | Established preventive, by age band | Same, for an existing patient | Periodicity schedule not checked pre-visit |
90460 / 90461 | Immunisation admin with counselling, first / each additional component | Counselling by a physician or QHP documented; component count | Billing 90471 instead, or not counting components on combination vaccines |
90471 / 90472 | Immunisation admin without counselling | Administration documented | Used where 90460 was supportable, under-collecting |
96110 | Developmental screening with scoring and report | Standardised instrument, scored, documented | Screening performed but never charged |
99392 + 99213-25 | Well visit plus separate problem | Distinct assessment and plan for the problem | Modifier 25 omitted, or applied without separate documentation |
ICD-10 nuances that matter here
Well-child encounters use Z00.110 through Z00.129, and the distinction between "with abnormal findings" and "without" must match the rest of the claim, billing a problem E/M alongside a "without abnormal findings" code is an internal contradiction payers notice. Developmental screening should carry the encounter code plus any documented concern. Where a child is seen for a condition rather than a well visit, code the condition to the specificity the note supports; unspecified paediatric codes weaken support for the testing and referrals ordered alongside.
Modifiers that carry the practice
- Separately identifiable problem visit at a well-child check, the single most-used modifier in the specialty, and the one payer analytics scrutinise hardest given how often well visits happen.
- Many state Medicaid programs require their own modifier (commonly EP) on Early and Periodic Screening, Diagnostic and Treatment visits, on top of or instead of the standard preventive coding. This is one of the clearest examples of why a single national ruleset fails multi-state paediatric billing.
- Applying one state's EPSDT modifier and frequency rules to a claim destined for a different state's Medicaid programme is a leading source of clean-looking claims that still deny. The code is right, the modifier is simply wrong for that payer.
NCCI edits and bundling
The well-visit-plus-problem pairing works exactly as it does in family medicine: a distinct, documented problem alongside a well visit is unbundled with modifier 25, and routine over-use of that pairing is what draws review. The paediatric-specific edit worth knowing is between the vaccine product and its administration code. These are companion codes, not competing ones, and the error that costs money is not a bundling conflict but the opposite: forgetting to bill the administration code at all when the product was given, which loses the fee entirely rather than triggering a denial that would at least surface the mistake.
Medically Unlikely Edits (MUEs)
Combination vaccines are the specialty's clearest MUE-adjacent issue: 90460 pays per component, with each additional component billed under its own add-on code, and a claim that under-counts components (billing one unit for a vaccine with three antigens) simply leaves money on the table rather than triggering any edit at all, which is precisely why it goes unnoticed. Developmental screening (96110) and immunisation administration both carry per-day ceilings tied to how many screenings or doses are clinically plausible in one visit; a well-run charge-capture process checks the vaccine record against the administration codes billed before the claim goes out, not after the remittance comes back.
Fee schedules: Medicaid variation and VFC economics
Paediatrics is unusual among the specialties in this guide because Medicaid, not Medicare, is the dominant government payer, and Medicaid fee schedules are set and updated independently by each state rather than on the single national MPFS cycle every other specialty in this guide references. A multi-state practice is tracking as many fee schedules as it has state Medicaid contracts, each on its own update calendar. Vaccines for Children doses add a second wrinkle: the product itself is supplied at no cost and is never billed, so 100% of a VFC-covered visit's vaccine revenue is the administration fee, which makes the administration code the entire financial event for that dose rather than a small add-on to a product charge.
Common denials and how to resolve them
| Denial | Why it happens | Resolution | Prevention |
|---|---|---|---|
| CO-151 frequency | Well visit billed ahead of the periodicity interval | Confirm the last well visit date; rebill when eligible | Schedule well visits against the payer interval, not only the clinical schedule |
| Vaccine product denied | VFC dose billed as practice stock | Rebill administration only, identifying the dose per state rules | Separate VFC and private inventory in the system, not just on the shelf |
| CO-97 bundled | Problem E/M with well visit, modifier 25 missing | Append modifier 25 where separate work is documented; appeal with the note | Scrubber rule for well visit + E/M pairs |
| Admin code underpaid | 90471 used where 90460 with components applied | Corrected claim with the counselling-based codes and component count | Default to 90460 where counselling is documented; count components |
| CO-16 missing information | Medicaid requires a state-specific field or identifier | Add the required data and resubmit | Per-state claim templates for multi-state practices |
| CO-22 COB | Divorced or dual-coverage households with stale primary on file | Rebill to the correct primary; update COB | Re-verify coverage at every visit for dual-coverage families |
Reconcile vaccine doses administered against vaccine claims paid every month, splitting VFC from private stock. Paediatric practices routinely discover that a small percentage of doses were given but never billed, and because vaccine is purchased inventory, that is real money already spent. The reconciliation takes an hour and usually pays for itself the first time it is run.
Do and don't
- Track VFC and private vaccine stock as separate inventories in the system.
- Use 90460/90461 with an accurate component count where counselling is documented.
- Check the periodicity interval before scheduling a well visit.
- Charge developmental screening every time it is performed and scored.
- Configure Medicaid rules per state where you operate across borders.
- Don't bill a VFC-supplied dose as practice stock under any circumstances.
- Don't default to 90471 when counselling was provided and documented.
- Don't assume one Medicaid ruleset covers multiple states.
- Don't let combination vaccines be billed as a single component.
- Don't skip COB re-verification for families with dual coverage.
Frequently asked questions
When should we use 90460 instead of 90471?
Use 90460 when a physician or other qualified health professional provided counselling about the vaccine to the patient or family, and that counselling is documented. It pays per component, so a combination vaccine covering several antigens generates 90460 plus 90461 for each additional component. 90471 applies where counselling was not provided or not documented. Practices that default to 90471 out of caution routinely leave meaningful revenue uncollected on every multi-component dose.
How do we handle VFC doses correctly?
VFC-supplied vaccine is provided at no cost, so the product itself is not billable. You bill the administration only, and identify the dose as VFC according to your state's requirements, which commonly involves a specific modifier or the product code at zero charge. The critical control is inventory separation: VFC and privately purchased stock must be distinguishable in your system, not merely on different shelves, or the billing will drift.
Why do our Medicaid claims deny more than commercial?
Medicaid programmes are administered per state, each with its own field requirements, prior-authorisation rules, referral expectations and managed-care plan variations. A claim format that clears in one state can reject in another for a missing identifier. Multi-state paediatric practices need per-state claim configuration and a payer matrix that is maintained, rather than a single ruleset that mostly works.
Can we bill a sick visit during a well-child check?
Yes, where a distinct problem is evaluated. Bill the preventive code plus the appropriate office visit with modifier 25 on the E/M, supported by a separate assessment and plan in the note. This is a legitimate and common pairing in paediatrics, but it is audited, so the documentation must show work beyond the routine well-visit content on its own terms.
Do you work with paediatric-specific EHR systems?
Yes. We work inside your existing system and its immunisation module rather than asking you to migrate. For paediatrics the first thing we usually build is the reconciliation between doses administered and vaccine claims paid, split by VFC and private stock, because that report reliably surfaces recoverable revenue in the first month.
Billing Pediatrics and losing revenue to denials?
We will audit a sample of your recent Pediatrics claims, identify the denial patterns specific to your payer mix, and show what is recoverable.